Human cell systems for drug discovery

Current Opinion in Drug Discovery and Development

Volumn 6, Issue 4, 2003, Pages 570-575

  Horrocks, Carolyn ^a   Halse, Reza ^a   Suzuki, Rami ^b   Shepherd, Peter R ^a,c  

^a Xcellsyz Ltd   (United Kingdom)

^b ITX Corporation   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Embryonic stem cells; Immortalization; Large T antigen; Telomerase; Transdifferentiation

Indexed keywords

RECOMBINANT PROTEIN; TELOMERASE;

ADIPOCYTE; CATALYSIS; CELL CULTURE; CELL LINE; CELL PROLIFERATION; CYTOGENETICS; CYTOLOGY; DRUG SAFETY; DRUG SCREENING; DRUG TARGETING; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE EPITHELIUM; KARYOTYPE; LEUKOCYTE; LIVER; MOLECULAR DYNAMICS; MUSCLE; NERVE CELL; ONCOGENE; PANCREAS ISLET BETA CELL; PROTEIN ISOLATION; REVIEW; SIGNAL TRANSDUCTION; SOMATIC CELL; STEM CELL; TECHNOLOGY; TELOMERE; VALIDATION PROCESS;

ANIMALS; CELL LINE; CYTOLOGICAL TECHNIQUES; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; HUMANS; STEM CELLS;

EID: 0041528395     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Daniele N, Halse R, Grinyo E, Yeaman SJ, Shepherd PR: Conditionally immortalized cell lines as model systems for high-throughput biology in drug discovery. Biochem Soc Trans (2002) 30(4):800-802.
2. Hertzberg RP, Pope AJ: High-throughput screening: New technology for the 21st Century. Curr Opin Chem Biol (2000) 4(4):445-451.
3. Rubin H: The disparity between human cell senescence in vitro and lifelong replication in vivo. Nat Biotechnol (2002) 20(7):675-681.
4. Bryan TM, Reddel RR: Telomere dynamics and telomerase activity in vitro immortalized human cells. Eur J Cancer (1997) 33(5):767-773.
5. Yeager TR, Reddel RR: Constructing immortalized human cell lines. Curr Opin Biotechnol (1999) 10(5):465-469.
6. Manfredi JJ, Prives C: The transforming activity of simian virus 40 large tumor antigen. Biochim Biophys Acta (1994) 1198(1):65-83.
7. Lee CM, Reddy EP: The v-myc oncogene. Oncogene (1999) 18(19):2997-3003.
8. Henson JD, Neumann AA, Yeager TR, Reddel RR: Alternative lengthening of telomeres in mammalian cells. Oncogene (2002) 21(4):598-610.
9. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE: Extension of life-span by introduction of telomerase into normal human cells. Science (1998) 279(5349):349-352. Telomerase can cause immortalization in some cell types.
10. O'Hare MJ, Bond J, Clarke C, Takeuchi Y, Atherton AJ, Berry C, Moody J, Silver AR, Davies DC, Alsop AE, Neville AM et al: Conditional immortalization of freshly isolated human mammary fibroblasts and endothelial cells. Proc Natl Acad Sci USA (2001) 98(2):646-651. T-antigen and telomerase act in a synergistic manner in immortalization.
11. Rybkin II, Markham DW, Yan Z, Bassel-Duby R, Williams RS, Olson EN: Conditional expression of SV40 T antigen in mouse cardiomyocytes facilitates an inducible switch from proliferation to differentiation. J Biol Chem (2003) 278(18):15927-15934.
12. Kobayashi N, Noguchi H, Westerman KA, Watanabe T, Matsumura T, Totsugawa T, Fujiwara T, Leboulch P, Tanaka N: Cre/IoxP-based reversible immortalization of human hepatocytes. Cell Transplant (2001) 10(4-5):383-386.
13. Jat PS, Sharp PA: Cell lines established by a temperature-sensitive simian virus 40 large-T-antigen gene are growth restricted at the nonpermissive temperature. Mol Cell Biol (1989) 9(4):1672-1681.
14. Obinata M: Possible applications of conditionally immortalized tissue cell lines with differentiation functions. Biochem Biophys Res Commun (2001) 286(4):667-672.
15. Jat PS, Noble MD, Ataliotis P, Tanaka Y, Yannoutsos N, Larsen L, Kioussis D: Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse. Proc Natl Acad Sci USA (1991) 88(12):5096-5100. This article describes the development of immortomouse, from which cell lines can be easily derived.
16. NIH Stem Cell Information: National Institutes of Health, Bethesda, MD, USA. http://www.nih.gov/news/stemcell/
17. Blau HM, Brazelton TR, Weimann JM: The evolving concept of a stem cell: Entity or function? Cell (2001) 105(7):829-841.
18. Amit M, Itskovitz-Eldor J: Derivation and spontaneous differentiation of human embryonic stem cells. J Anat (2002) 200(Pt 3):225-232.
19. Marek CJ, Cameron GA, Elrick LJ, Hawksworth GM, Wright MC: Generation of hepatocytes expressing functional cytochromes P450 from a pancreatic progenitor cell line in vitro. Biochem J (2003) 370(Pt 3):763-739. This publication describes a method for the transdifferentiation of pancreatic cells into liver cells possessing good functional characteristics.
20. Zhou J, Wang X, Pineyro MA, Egan JM: Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells. Diabetes (1999) 48(12):2358-2366.
21. ECACC, Centre for Applied Microbiology & Research, Salisbury, UK. http://www.ecacc.org/
22. American Type Culture Collection, Manassas, VA, USA. http://www.atcc.org
23. Halse R, Pearson SL, McCormack JG, Yeaman SJ, Taylor R: Effects of tumor necrosis factor-α on insulin action in cultured human muscle cells. Diabetes (2001) 50(5):1102-1109.
24. Lawson MA, Purslow PP: Differentiation of myoblasts in serum-free media: Effects of modified media are cell line-specific. Cells Tissues Organs (2000) 167(2-3):130-137.
25. Mouly V, Edom F, Decary S, Vicart P, Barbert JP, Butler-Browne GS: SV40 large T antigen interferes with adult myosin heavy chain expression, but not with differentiation of human satellite cells. Exp Cell Res (1996) 225(2):268-276.
26. Morgan JE, Beauchamp JR, Pagel CN, Peckham M, Ataliotis P, Jat P, Noble MD, Farmer K, Partridge TA: Myogenic cell lines derived from transgenic mice carrying a thermolabile T-antigen: A model system for derivation of tissue specific and mutation specific cell lines. Dev Biol (1994) 162(2):486-498. This paper highlights the quality of conditionally immortalized cell lines derived from immortomouse, by showing that cells regain in vivo functionality when re-implanted into the mice.
27. Brunskill EW, Witte DP, Yutzey KE, Potter SS: Novel cell lines promote the discovery of genes involved in early heart development. Dev Biol (2001) 235(2):507-520.
28. Jahn L, Sadoshima J, Greene A, Parker C, Morgan KG, Izumo S: Conditional differentiation of heart- and smooth muscle-derived cells transformed by a temperature-sensitive mutant of SV40 T antigen. J Cell Sci (1996) 109(Pt 2):397-407.
29. Lavon, N, Benvenisty N: Differentiation and genetic manipulation of human embryonic stem cells and the analysis of the cardiovascular system. Trends Cardiovasc Med (2003) 13(2):47-52.
30. Runge D, Michalopoulos GK, Strom SC, Runge DM: Recent advances in human hepatocyte culture systems. Biochem Biophys Res Commun (2000) 274(1):1-3.
31. Pfeifer AM, Cole KE, Smoot DT, Weston A, Groopman JD, Shields PG, Vignaud JM, Juillerat M, Lipsky MM, Trump BF: Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens. Proc Natl Acad Sci USA (1993) 90(11):5123-5127.
32. Schippers IJ, Moshage H, Roelofsen H, Muller M, Heymans HS, Ruiters M, Kulpers F: Immortalized human hepatocytes as a tool for the study of hepatocytic (de-)differentiation. Cell Biol Toxicol (1997) 13(4-5):375-386.
33. Schmiedlin-Ren P, Thummel KE, Fisher JM, Paine MF, Watkins PB: Induction of CYP3A4 by 1α,25-dihydroxyvitamin D3 is human cell line-specific and is unlikely to involve pregnane X receptor. Drug Metab Dispos (2001) 29(11):1446-1453.
34. Kunieda T, Kobayashi N, Sakaguchi M, Okitsu T, Totsugawa T, Watanabe T, Matsumura T, Maruyama M, Noguchi H, Takesue M, Shibata N et al: Transduction of immortalized human hepatocytes with p21 to enhance differentiated phenotypes. Cell Transplant (2002) 11(5):421-428.
35. Vescovi AL, Snyder EY: Establishment and properties of neural stem cell clones: Plasticity in vitro and in vivo. Brain Pathol (1999) 9(3):569-598.
36. Villa A, Snyder EY, Vescovi A, Martinez-Serrano A: Establishment and properties of a growth factor-dependent, perpetual neural stem cell line from the human CNS. Exp Neurol (2000) 161(1):67-84.
37. Redies C, Lendahl U, McKay RD: Differentiation and heterogeneity in T-antigen immortalized precursor cell lines from mouse cerebellum. J Neurosci Res (1991) 30(4):601-615.
38. Sinden JD, Rashid-Doubell F, Kershaw TR, Nelson A, Chadwick A, Jat PS, Noble MD, Hodges H, Gray JA: Recovery of spatial learning by grafts of conditionally immortalized hippocampal neuroepithelial cell line into the ischaemia lesioned hippocampus. Neuroscience (1997) 81(3):599-608. Conditionally immortalized neural cell lines can be used for tissue repair in vivo.
39. Mandrup S, Sorensen RV, Heiledle T, Nohr J, Baldursson T, Gram C, Knudsen J, Kristiansen K: Inhibition of 3T3-L1 adipocyte differentiation by expression of acyl-CoA-binding protein antisense RNA. J Biol Chem (1998) 273(37):23897-23903.
40. Green H, Kehinde O: An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell (1975) 5(1):19-27.
41. 3-adrenoceptor coupled to lipolysis. J Cell Sci (1997) 110(Pt 7):801-807.
42. Blais A, Aymard P, Lacour B: Paracellular calcium transport across Caco-2 and HT29 cell monolayers. Pflug Arch Eur J Physiol (1997) 434(3):300-305.
43. Laska DA, Houchins JO, Pratt SE, Horn J, Xia X, Hanssen BR, Williams DC, Dantzig AH, Lindstrom T: Characterization and application of a vinblastine-selected Caco-2 cell line for evaluation of P-glycoprotein. In Vitro Cell Dev Biol (2002) 38(7):401-410.
44. Ulrich AB, Schmied BM, Standop J, Schneider MB, Pour PM: Pancreatic cell lines: A review. Pancreas (2002) 24(2):111-120.
45. + channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes (2000) 49(3):424-430.
46. Miyazaki J, Araki K, Yamato E, Ikegami H, Asano T, Shibasaki Y, Oka Y, Yamamura K: Establishment of a pancreatic β cell line that retains glucose-inducible insulin secretion: Special reference to expression of glucose transporter isoforms. Endocrinology (1990) 127(1):126-132.